Lundbeck to acquire Prexton Therapeutics, participated by Ysios Capital, in a deal valued at up to €905 million

by Ysios Capital

H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) have announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under terms of the agreement, Lundbeck wil...

Read more

Prexton Therapeutics - participated by Ysios Capital - Series B financing round raises € 29 millions to advance its novel Parkinson’s therapeutic

by Ysios Capital

Forbion Capital Partners (NL) and Seroba Life Sciences (IE) co-led the financing round, which includes current investors Merck Ventures (NL), Ysios Capital (ES) and Sunstone Capital (DK). Marco Boorsm...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Estrategias de Negociación con Inversor...

by Foro Capital Pymes

La negociación con inversores es un paso crucial y a menudo intimidan...

Photos Stream